Introduction
Osteosarcoma, which accounts for approximately 60% of malignant bone tumors observed in children and adolescents . Osteosarcoma frequently occurs in the long bones and preferentially metastasizes to the lung . The treatment for osteosarcoma is very challenging. Although the introduction of chemotherapy has reduced the mortality, more than 50% of patients who are chemoresistant have an extremely poor prognosis due metastatic disease can reach up to 60-70%, while in patients with metastatic disease, it . Molecular pathways contributing to osteosarcoma development and progression have recently been discovered. Various studies have been carried out to investigate the genes that are involved in the metastasis of osteosarcoma . This may facilitate better diagnosis, as well as the development of new treatment strategies. Despite the molecular alterations that contribute to the metastasis of osteosarcomas, osteosarcomas are becoming increasingly understood. However, the highly complex molecular mechanisms of metastasis are still poorly understood. Recently, microRNAs have become a new research level by inhibiting the translation of an mRNA or by promoting mRNA degradation, are .
. However, most of the biological functions of these genes remain unknown, and only a few mRNAs that are directly regulated tissues and their normal tissue counterparts have revealed distinct miRNA expression Various studies have investigated the role of miRNAs in osteosarcoma using miRNA ability of the MG63 osteosarcoma cell line. Kobayashi et al. 
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Inhibition of miR-27a inhibits the migration and invasion of MG63 cells
Transwell migration and invasion assays were performed to determine whether migration and invasion of osteosarcoma in vitro.
MAP4K4 silencing prevents the effect of miR-27a Inhibition on MG63 cells
To decrease the expression of MAP2K4, the MG63 cell lines were transfected with MAP2K4 MAP2K4 contained substantially lower levels of MAP2K4 protein (Fig. 3 A) than the cells transfected with control siRNA.
To evaluate the effects of MAP4K4 on the proliferation, migration and invasion of MG63 osteosarcoma cells, MTT and transwell assays were performed following the procedures described in the Methods section. During this time course, the MG63 cell line showed a (Fig. 3 BC) .
miR-27a directly targets the MAP2K4 3'UTR
MAP2K4
MAP2K4 through the two predicted binding sites, the MAP2K4 pGL3 vector downstream of the luciferase reporter gene (Fig. 4B) . Mutations in the putative binding sites were prepared as described in the Materials and Methods section. As expected, pGL3-MAP2K4 pGL3-MAP2K4 vector (Fig. 4D) . These results demonstrated that MAP2K4
Inhibition of miR-27a increases the expression of MAP2K4 in MG63 cells
MAP2K4
inhibitor, and the results showed that the protein level of MAP2K4 MAP2K4 protein levels.
MAP2K4 can regulate various cellular activities such as proliferation, differentiation, and apoptosis by activating the JNK/p38 signaling pathway, thus inhibiting tumor metastasis JNK1 and p38 inhibitor, the level of phospho-JNK1 and phospho-p38 along with an increase in the level of MAP2K4 may be involved in the JNK/p38 signaling pathway by affecting MAP2K4 expression.
Discussion
steps during cancer progression. More and more emerging evidence has indicated that miRNAs may play regulatory roles in cell proliferation and metastasis of cancer in humans . Therefore, to understand the functional mechanism of miRNAs, it is paramount to identify the targets that are involved in the regulation process. Recently, overexpression . Our study demonstrated that the in vitro role in the development of osteosarcoma. 
